{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T13:43:20Z","timestamp":1786196600413,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T00:00:00Z","timestamp":1551657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2018-1-2151"],"award-info":[{"award-number":["2018-1-2151"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13045-019-0706-9","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T09:08:01Z","timestamp":1551690481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["Mortality of lymphoma and myeloma in China, 2004\u20132017: an observational study"],"prefix":"10.1186","volume":"12","author":[{"name":"Union for China Leukemia Investigators of the Chinese Society of Clinical Oncology, Union for China Lymphoma Investigators of the Chinese Society of Clinical Oncology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maigeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3479-2547","authenticated-orcid":false,"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,4]]},"reference":[{"key":"706_CR1","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375\u201390.","journal-title":"Blood"},{"issue":"11","key":"706_CR2","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jamaoncol.2018.2706","volume":"4","author":"C Fitzmaurice","year":"2018","unstructured":"Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Akinyemiju TF, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study. JAMA Oncol. 2018;4(11):1553\u201368.","journal-title":"JAMA Oncol"},{"key":"706_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3322\/caac.21357","volume":"66","author":"LR Teras","year":"2016","unstructured":"Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016;66:443\u201359.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"706_CR4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2016.20324","volume":"317","author":"AH Mokdad","year":"2017","unstructured":"Mokdad AH, Dwyer-Lindgren L, Fitzmaurice C, et al. Trends and patterns of disparities in cancer mortality among US counties, 1980-2014. JAMA. 2017;317(4):388\u2013406.","journal-title":"JAMA"},{"key":"706_CR5","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4143\/crt.2017.093","volume":"50","author":"H Lee","year":"2018","unstructured":"Lee H, Park HJ, Park EH, et al. Nationwide statistical analysis of lymphoid malignancies in Korea. Cancer Res Treat. 2018;50:222\u201338.","journal-title":"Cancer Res Treat"},{"key":"706_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0140-6736(15)00551-6","volume":"387","author":"M Zhou","year":"2016","unstructured":"Zhou M, Wang H, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the global burden of disease study 2013. Lancet. 2016;387:251\u201372.","journal-title":"Lancet"},{"key":"706_CR7","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1016\/S2214-109X(16)30360-6","volume":"5","author":"M Zhou","year":"2017","unstructured":"Zhou M, Wang H. National and regional under-5 mortality in China in the past two decades. Lancet Glob Health. 2017;5:e121\u20132.","journal-title":"Lancet Glob Health"},{"issue":"10015","key":"706_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0140-6736(15)00554-1","volume":"387","author":"Y Wang","year":"2016","unstructured":"Wang Y, Li X, Zhou M, et al. Under-5 mortality in 2851 Chinese counties, 1996-2012: a subnational assessment of achieving MDG 4 goals in China. Lancet. 2016;387(10015):273\u201383.","journal-title":"Lancet"},{"key":"706_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2471\/BLT.15.153148","volume":"94","author":"S Liu","year":"2016","unstructured":"Liu S, Wu X, Lopez AD, et al. An integrated national mortality surveillance system for death registration and mortality surveillance, China. Bull World Health Organ. 2016;94:46\u201357.","journal-title":"Bull World Health Organ"},{"issue":"12","key":"706_CR10","first-page":"1061","volume":"45","author":"L Wang","year":"2011","unstructured":"Wang L, Wang LJ, Cai Y, Ma LM, Zhou MG. Analysis of under-reporting of mortality surveillance from 2006 to 2008 in China. Zhonghua Yu Fang Yi Xue Za Zhi. 2011;45(12):1061\u20134.","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"706_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12963-015-0051-3","volume":"13","author":"K Guo","year":"2015","unstructured":"Guo K, Yin P, Wang L, et al. Propensity score weighting for addressing under-reporting in mortality surveillance: a proof-of-concept study using the nationally representative mortality data in China. Popul Health Metrics. 2015;13:16.","journal-title":"Popul Health Metrics"},{"issue":"6","key":"706_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"706_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"706_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115\u201332.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"706_CR15","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1038\/bjc.2015.94","volume":"112","author":"A Smith","year":"2015","unstructured":"Smith A, Crouch S, Lax S, et al. Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK\u2019s Haematological Malignancy Research Network. Br J Cancer. 2015;112(9):1575\u201384.","journal-title":"Br J Cancer"},{"issue":"3","key":"706_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/bjh.15532","volume":"183","author":"KA Blum","year":"2018","unstructured":"Blum KA, Keller FG, Castellino S, Phan A, Flowers CR. Incidence and outcomes of lymphoid malignancies in adolescent and young adult patients in the United States. Br J Haematol. 2018;183(3):385\u201399.","journal-title":"Br J Haematol"},{"key":"706_CR17","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1093\/annonc\/mdx342","volume":"28","author":"F Islami","year":"2017","unstructured":"Islami F, Chen W, Yu XQ, et al. Cancer deaths and cases attributable to lifestyle factors and infections in China, 2013. Ann Oncol. 2017;28:2567\u201374.","journal-title":"Ann Oncol"},{"key":"706_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21147\/j.issn.1000-9604.2018.01.01","volume":"30","author":"W Chen","year":"2018","unstructured":"Chen W, Sun K, Zheng R, et al. Cancer incidence and mortality in China, 2014. Chin J Cancer Res. 2018;30:1\u201312.","journal-title":"Chin J Cancer Res"},{"key":"706_CR19","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","volume":"103","author":"J Ferlay","year":"2018","unstructured":"Ferlay J, Colombet M, Soerjomataram I, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356\u201387.","journal-title":"Eur J Cancer"},{"key":"706_CR20","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","volume":"390","author":"GBD 2016 Causes of Death Collaborators","year":"2017","unstructured":"GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1151\u2013210.","journal-title":"Lancet"},{"key":"706_CR21","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023\u201375.","journal-title":"Lancet"},{"key":"706_CR22","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/S2214-109X(18)30127-X","volume":"6","author":"H Zeng","year":"2018","unstructured":"Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 2018;6:e555\u201367.","journal-title":"Lancet Glob Health"},{"key":"706_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12913-016-1426-2","volume":"16","author":"C Huang","year":"2016","unstructured":"Huang C, Liu CJ, Pan XF, et al. Correlates of unequal access to preventive care in China: a multilevel analysis of national data from the 2011 China Health and Nutrition Survey. BMC Health Serv Res. 2016;16:177.","journal-title":"BMC Health Serv Res"},{"key":"706_CR24","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/1472-6963-14-305","volume":"14","author":"J Wang","year":"2014","unstructured":"Wang J, Chen L, Ye T, et al. Financial protection effects of modification of China\u2019s new cooperative medical scheme on rural households with chronic diseases. BMC Health Serv Res. 2014;14:305.","journal-title":"BMC Health Serv Res"},{"issue":"12","key":"706_CR25","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1377\/hlthaff.2009.0989","volume":"29","author":"W Jian","year":"2010","unstructured":"Jian W, Chan KY, Reidpath DD, et al. China's rural-urban care gap shrank for chronic disease patients, but inequities persist. Health Aff (Millwood). 2010;29(12):2189\u201396.","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"706_CR26","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12939-017-0706-8","volume":"16","author":"D Zhu","year":"2017","unstructured":"Zhu D, Guo N, Wang J, et al. Socioeconomic inequalities of outpatient and inpatient service utilization in China: personal and regional perspectives. Int J Equity Health. 2017;16(1):210.","journal-title":"Int J Equity Health"},{"issue":"8","key":"706_CR27","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1002\/ijc.29227","volume":"136","author":"H Zeng","year":"2015","unstructured":"Zeng H, Zheng R, Guo Y, et al. Cancer survival in China, 2003-2005: a population-based study. Int J Cancer. 2015;136(8):1921\u201330.","journal-title":"Int J Cancer"},{"issue":"6042","key":"706_CR28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1126\/science.1209396","volume":"333","author":"X Peng","year":"2011","unstructured":"Peng X. China's demographic history and future challenges. Science. 2011;333(6042):581\u20137.","journal-title":"Science"},{"issue":"9818","key":"706_CR29","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0140-6736(12)60278-5","volume":"379","author":"Q Meng","year":"2012","unstructured":"Meng Q, Xu L, Zhang Y, et al. Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study. Lancet. 2012;379(9818):805\u201314.","journal-title":"Lancet"},{"issue":"5","key":"706_CR30","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(14)70029-4","volume":"15","author":"PE Goss","year":"2014","unstructured":"Goss PE, Strasser-Weippl K, Lee-Bychkovsky BL, et al. Challenges to effective cancer control in China, India, and Russia. Lancet Oncol. 2014;15(5):489\u2013538.","journal-title":"Lancet Oncol"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-019-0706-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13045-019-0706-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-019-0706-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T19:38:37Z","timestamp":1583177917000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-019-0706-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,4]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["706"],"URL":"https:\/\/doi.org\/10.1186\/s13045-019-0706-9","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,4]]},"assertion":[{"value":"19 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"22"}}